South Korean Pharmaceuticals & Biotech Large Cap High Growth Potential

Results

0 new

Large Cap Companies that analysts expect to have high earnings, revenue or cash flow growth in the next 3 years.

2 companies

ALTEOGEN

Market Cap: ₩26.1t

A bio company, focuses on developing long-acting biobetters, proprietary antibody-drug conjugates, and antibody biosimilars.

A196170

₩488,500.00

9.5%

37.0%

Celltrion

Market Cap: ₩38.7t

A biopharmaceutical company, engages in the development, production, and sale of various therapeutic proteins for the treatment of oncology diseases.

A068270

₩175,600.00

1.6%

5.9%